ABSTRACT

Obesity is a chronic complex disorder characterized by excess weight or body fat that might affect their health resulting in unfavorable metabolic, biomechanical, and psychosocial health cost caused by the interaction of numerous genetic, dietary, lifestyle, and environmental factors. The pharmacologic management of adult obesity was summarized by food and drug administration (FDA)-approved medications. The mainstream of these medications are taken orally, and only one is administered subcutaneously. Psyllium Husk is an enormous source of nutritional fiber. It helps in the provision of satiety and good control over appetite. It helps to decrease your hunger without affecting the energy levels. This aids weight loss with minimal side effects compares to others drugs. FDA approved weight loss drugs have minimal to modest effects on the cardiometabolic risk profile of obese and overweight adults. So in order to control the epidemic a new challenge to public health professionals is the main risk factors. Prevention of obesity should receive high priority. Keywords: Orlistat, Lorcaserin, Phentermine, and Topiramate, Naltrexone and Bupropion, Liraglutide, Psyllium Husk
Publication date: 01/06/2020

https://ijbpas.com/pdf/2020/June/MS_IJBPAS_2020_5093.pdf

Download PDF
https://doi.org/10.31032/IJBPAS/2020/9.6.5093